These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 79391)

  • 1. Oestrogen-induced changes in uterine cGMP: effects in vitro of oestradiol-17 beta [proceedings].
    Flandroy L; Galand P
    Arch Int Physiol Biochim; 1977 Dec; 85(5):975-7. PubMed ID: 79391
    [No Abstract]   [Full Text] [Related]  

  • 2. Oestrogen-related changes in uterine and vaginal cAMP and cGMP.
    Flandroy L; Galand P
    Arch Int Physiol Biochim; 1975 Dec; 83(5):965-7. PubMed ID: 58624
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct regulation of nitric oxide and cyclic guanosine monophosphate production by steroid hormones in the rat uterus.
    Buhimschi IA; Yallampalli C; Buhimschi CS; Saade GR; Garfield RE
    Mol Hum Reprod; 2000 May; 6(5):404-14. PubMed ID: 10775643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen-induced changes in uterine cGMP: relationship with other parameters of hormonal stimulation [proceedings].
    Flandroy L; Fastrez-Boute A; Galand P
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1072-4. PubMed ID: 65997
    [No Abstract]   [Full Text] [Related]  

  • 5. Oestrogen-induced increase in uterine cGMP content: a true hormonal action?
    Flandroy L; Galand P
    Mol Cell Endocrinol; 1979 Mar; 13(3):281-90. PubMed ID: 221291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation by epidermal growth factor of the estradiol-induced increase in cyclic guanosine 3',5'-monophosphate content in the rat uterus.
    Galand P; Rooryck J
    Endocrinology; 1996 May; 137(5):1932-7. PubMed ID: 8612533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of estrogen-induced increases in uterine guanosine 3',5'-cyclic monophosphate levels by inhibitors of protein and RNA synthesis.
    Nicol SE; Goldberg ND
    Biochemistry; 1976 Dec; 15(25):5490-6. PubMed ID: 187218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen-induced increase in uterine cGMP content in vitro: effects of inhibitors of protein and RNA synthesis.
    Flandroy L; Galand P
    Mol Cell Endocrinol; 1982 Jan; 25(1):49-54. PubMed ID: 6175545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation by colchicine of the wet weight and the cGMP responses to estradiol in immature rat uterus.
    Alexandre K; Rooryck J; Galand P
    J Steroid Biochem; 1988 Dec; 31(6):873-5. PubMed ID: 2848986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cycloheximide on the uterine refractory state induced by 'nidatory' oestrogen in rats.
    Leroy F; Van Hoeck J; Lejeune B
    J Reprod Fertil; 1979 May; 56(1):187-91. PubMed ID: 469840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in brain, pituitary and uterine cytoplasmic oestrogen receptors induced by oestradiol-17beta in the ovariectomized rat.
    Morris ID
    J Endocrinol; 1976 Dec; 71(3):343-9. PubMed ID: 1003063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cGMP and cAMP content in the estrogen-stimulated rat uterus: temporal relationship with other parameters of hormonal stimulation.
    Flandroy L; Galand P
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):145-58. PubMed ID: 207753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between theophylline and oestrogen in the rat uterus.
    Steinsapir J; Rojas AM; Fernández A; Alburquerque M; León S; Bustón P; Pacheco R; Munizaga A; Habash L; Ojeda JM; Tchernitchin A
    J Endocrinol; 1979 Dec; 83(3):277-84. PubMed ID: 536665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear oestrogen receptor in the female rat. Effects of oestradiol administration during the oestrous cycle on the uterus and contrasting effects of progesterone on the uterus and hypothalamus.
    Thrower S; Lim L
    Biochem J; 1981 Aug; 198(2):385-9. PubMed ID: 7198913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic regulation of estradiol uptake and cyclic GMP content in rat uterus.
    Kano T; Ishii K; Kurobe Y; Ando J
    Jpn J Pharmacol; 1983 Jun; 33(3):525-9. PubMed ID: 6312146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related increases in uterine guanosine 3':5'-cyclic momophosphate levels.
    Kuehl FA; Ham EA; Zanetti ME; Sanford CH; Nicol SE; Goldberg ND
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1866-70. PubMed ID: 4365763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-induced alterations in cyclic nucleotide and prostaglandin levels in target tissue.
    Kuehl FA; Zanetti ME; Cirillo VJ; Ham EA
    J Steroid Biochem; 1975 Jun; 6(6):1099-105. PubMed ID: 170459
    [No Abstract]   [Full Text] [Related]  

  • 18. Histone acetylation and hormone action. Early effects of oestradiol-17beta on histone acetylation in rat uterus.
    Libby PR
    Biochem J; 1972 Dec; 130(3):663-9. PubMed ID: 4664926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen levels in the blood, not in the uterus, determine uterine eosinophilia and oedema.
    Tchernitchin AN; Galand P
    J Endocrinol; 1983 Oct; 99(1):123-30. PubMed ID: 6631303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of oestrogen-induced uterine peroxidase.
    McNabb T; Jellinck PH
    Biochem J; 1975 Nov; 151(2):275-9. PubMed ID: 1240756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.